{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:09:40Z","timestamp":1785841780317,"version":"3.56.0"},"reference-count":49,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Severe SARS-CoV-2 infection is linked with an overstated immune response with the\nsucceeding release of pro-inflammatory cytokines and progression of the cytokine storm. In addition,\nsevere SARS-CoV-2 infection is associated with the development of oxidative stress and coagulopathy.\nDapsone (DPS) is a bacteriostatic antibiotic that has a potent anti-inflammatory effect.\nThus, this mini-review aimed to elucidate the potential role of DPS in mitigating inflammatory\ndisorders in COVID-19 patients. DPS inhibits neutrophil myeloperoxidase, inflammation, and neutrophil\nchemotaxis. Therefore, DPS could be effective against neutrophilia-induced complications\nin COVID-19. In addition, DPS could be effective in mitigating inflammatory and oxidative stress\ndisorders by suppressing the expression of inflammatory signaling pathways and the generation of\nreactive oxygen species (ROS) correspondingly. In conclusion, DPS might be effective in the management\nof COVID-19 through the attenuation of inflammatory disorders. Therefore, preclinical\nand clinical studies are reasonable in this regard.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207326666230331121735","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:57:11Z","timestamp":1680289031000},"page":"674-678","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Potential Effect of Dapsone on the Inflammatory Reactions in\nCOVID-19: Staggering View"],"prefix":"10.2174","volume":"27","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Medicine, College of Medicine, AL-Mustansiriyia University, Baghdad,\nIraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Medicine, College of Medicine, AL-Mustansiriyia University, Baghdad,\nIraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8287-1026","authenticated-orcid":true,"given":"Engy","family":"Elekhnawy","sequence":"additional","affiliation":[{"name":"Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[{"name":"Department of\nScience and Engineering, Novel Global Community Educational Foundation, Hebersham, Australia"},{"name":"AFNP Med Austria,\nWien, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University,\nDamanhour 22511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"642181","DOI":"10.3389\/fcvm.2021.642181","volume":"8","author":"Al-kuraishy HM","year":"2021","unstructured":"Al-kuraishy HM; Al-Gareeb AI; Abdullah SM; Cruz-Martins N; Batiha GE; Case Report: Hyperbilirubinemia in gilbert syndrome attenuates COVID-19-induced metabolic disturbances. Front Cardiovasc Med  2021,8,642181","journal-title":"Front Cardiovasc Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/2305-0500.282984","volume":"9","author":"Al-kuraishy H.","year":"2020","unstructured":"Al-kuraishy H.; Al-Maiahy T.; Al-Gareeb A.; Musa R.; Ali Z.; COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery. Asian Pac J Reprod  2020,9(3),156","journal-title":"Asian Pac J Reprod"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/bbrj.bbrj_103_20","volume":"4","author":"Al-Kuraishy H.","year":"2020","unstructured":"Al-Kuraishy H.; Al-Naimi M.; Lungnier C.; Al-Gareeb A.; Macrolides and COVID-19: An optimum premise. Biomed Biotechnol Res J  2020,4(3),189","journal-title":"Biomed Biotechnol Res J"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/bbrj.bbrj_105_20","volume":"4","author":"Al-Kuraishy H.M.","year":"2020","unstructured":"Al-Kuraishy H.M.; Hussien N.R.; Al-Naimi M.S.; Al-Buhadily A.K.; Al-Gareeb A.I.; Lungnier C.; Renin\u2013Angiotensin system and fibrinolytic pathway in COVID-19: One-way skepticism. Biomed Biotechnol Res J  2020,4(5),33","journal-title":"Biomed Biotechnol Res J"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/bbrj.bbrj_109_20","volume":"4","author":"Al-Kuraishy H.M.","year":"2020","unstructured":"Al-Kuraishy H.M.; Hussien N.R.; Al-Naimi M.S.; Al-Buhadily A.K.; Al-Gareeb A.I.; Lungnier C.; Is ivermectin\u2013Azithromycin combination the next step for COVID-19? Biomed Biotechnol Res J  2020,4(5),101","journal-title":"Biomed Biotechnol Res J"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.intimp.2009.11.005","volume":"10","author":"Bao Z.","year":"2010","unstructured":"Bao Z.; Ye Q.; Gong W.; Xiang Y.; Wan H.; Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol  2010,10(2),259-263","journal-title":"Int Immunopharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"Barnes B.J.","year":"2020","unstructured":"Barnes B.J.; Adrover J.M.; Baxter-Stoltzfus A.; Borczuk A.; Cools-Lartigue J.; Crawford J.M.; Da\u00dfler-Plenker J.; Guerci P.; Huynh C.; Knight J.S.; Loda M.; Looney M.R.; McAllister F.; Rayes R.; Renaud S.; Rousseau S.; Salvatore S.; Schwartz R.E.; Spicer J.D.; Yost C.C.; Weber A.; Zuo Y.; Egeblad M.; Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med  2020,217(6),e20200652","journal-title":"J Exp Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/antiox9100936","volume":"9","author":"Beltr\u00e1n-Garc\u00eda J.","year":"2020","unstructured":"Beltr\u00e1n-Garc\u00eda J.; Osca-Verdegal R.; Pallard\u00f3 F.V.; Ferreres J.; Rodr\u00edguez M.; Mulet S.; Sanchis-Gomar F.; Carbonell N.; Garc\u00eda-Gim\u00e9nez J.L.; Oxidative stress and inflammation in COVID-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants  2020,9(10),936","journal-title":"Antioxidants"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","volume":"98","author":"Booth S.A.","year":"1992","unstructured":"Booth S.A.; Moody C.E.; Dahl M.V.; Herron M.J.; Nelson R.D.; Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol  1992,98(2),135-140","journal-title":"J Invest Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"110412","DOI":"10.1016\/j.mehy.2020.110412","volume":"146","author":"Carcaterra M.","year":"2021","unstructured":"Carcaterra M.; Caruso C.; Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory. Med Hypotheses  2021,146,110412","journal-title":"Med Hypotheses"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/vaccines10020195","volume":"10","author":"Kanwar B.A.","year":"2022","unstructured":"Kanwar B.A.; Khattak A.; Balentine J.; Lee J.H.; Kast R.E.; Benefits of using dapsone in patients hospitalized with COVID-19. Vaccines  2022,10(2),195","journal-title":"Vaccines"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"15563","DOI":"10.3390\/ijms232415563","volume":"23","author":"Kanwar B.","year":"2022","unstructured":"Kanwar B.; Khattak A.; Kast R.E.; Dapsone lowers neutrophil to lymphocyte ratio and mortality in COVID-19 patients admitted to the ICU. Int J Mol Sci  2022,23(24),15563","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"902206","DOI":"10.3389\/fimmu.2022.902206","volume":"13","author":"Ventura-Santana E.","year":"2022","unstructured":"Ventura-Santana E.; Ninan J.R.; Snyder C.M.; Okeke E.B.; Neutrophil extracellular traps, sepsis and COVID-19 \u2013 A tripod stand. Front Immunol  2022,13,902206","journal-title":"Front Immunol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","volume":"10","author":"Chen I.Y.","year":"2019","unstructured":"Chen I.Y.; Moriyama M.; Chang M.F.; Ichinohe T.; Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol  2019,10,50","journal-title":"Front Microbiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/jmv.26521","volume":"93","author":"Dey J.","year":"2021","unstructured":"Dey J.; Alam M.T.; Chandra S.; Gupta J.; Ray U.; Srivastava A.K.; Tripathi P.P.; Neuroinvasion of SARS\u2010CoV\u20102 may play a role in the breakdown of the respiratory center of the brain. J Med Virol  2021,93(3),1296-1303","journal-title":"J Med Virol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1002\/jnr.21775","volume":"86","author":"Diaz-Ruiz A.","year":"2008","unstructured":"Diaz-Ruiz A.; Zavala C.; Montes S.; Ortiz-Plata A.; Salgado-Ceballos H.; Orozco-Suarez S.; Nava-Ruiz C.; P\u00e9rez-Neri I.; Perez-Severiano F.; R\u00edos C.; Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia\/reperfusion in rats. J Neurosci Res  2008,86(15),3410-3419","journal-title":"J Neurosci Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.clindermatol.2021.01.007","volume":"39","author":"Drenovska K.","year":"2021","unstructured":"Drenovska K.; Vassileva S.; Tanev I.; Joly P.; Impact of COVID-19 on autoimmune blistering diseases. Clin Dermatol  2021,39(3),359-368","journal-title":"Clin Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e14507","DOI":"10.1111\/dth.14507","volume":"34","author":"Elmas \u00d6.F.","year":"2021","unstructured":"Elmas \u00d6.F.; Demirba\u015f A.; Ba\u011fc\u0131er F.; T\u00fcrsen \u00dc.; Atasoy M.; Dursun R.; Lotti T.; Treatment considerations for Beh\u00e7et disease in the era of COVID \u201019: A narrative review. Dermatol Ther  2021,34(1),e14507","journal-title":"Dermatol Ther"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-022-00252-6","volume":"23","author":"Elekhnawy E.","year":"2022","unstructured":"Elekhnawy E.; Negm W.A.; The potential application of probiotics for the prevention and treatment of COVID-19. Egypt J Med Hum Genet  2022,23(1),1-9","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"109768","DOI":"10.1016\/j.mehy.2020.109768","volume":"140","author":"Farouk A.","year":"2020","unstructured":"Farouk A.; Salman S.; Dapsone and doxycycline could be potential treatment modalities for COVID-19. Med Hypotheses  2020,140,109768","journal-title":"Med Hypotheses"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1007\/s11033-022-07822-2","volume":"49","author":"Al-kuraishy H.M.","year":"2022","unstructured":"Al-kuraishy H.M.; Al-Gareeb A.I.; Elekhnawy E.; Batiha G.E.S.; Nitazoxanide and COVID-19: A review. Mol Biol Rep  2022,49(11),11169-11176","journal-title":"Mol Biol Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.3390\/ijms21175953","volume":"21","author":"Lee J.","year":"2020","unstructured":"Lee J.; An H.K.; Sohn M.G.; Kivela P.; Oh S.; 4,4\u2032-Diaminodiphenyl Sulfone (DDS) as an inflammasome competitor. Int J Mol Sci  2020,21(17),5953","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/bpa.12483","volume":"27","author":"Heneka M.T.","year":"2017","unstructured":"Heneka M.T.; Inflammasome activation and innate immunity in Alzheimer\u2019s disease. Brain Pathol  2017,27(2),220-222","journal-title":"Brain Pathol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.15441\/ceem.17.253","volume":"5","author":"Kang C.","year":"2018","unstructured":"Kang C.; Kim D.H.; Kim T.; Lee S.H.; Jeong J.H.; Lee S.B.; Kim J.H.; Jung M.H.; Lee K.; Park I.S.; Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats. Clin Exp Emerg Med  2018,5(3),192-198","journal-title":"Clin Exp Emerg Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/vaccines9060635","volume":"9","author":"Kanwar B.","year":"2021","unstructured":"Kanwar B.; Lee C.J.; Lee J.H.; Specific treatment exists for SARS-CoV-2 ARDS. Vaccines  2021,9(6),635","journal-title":"Vaccines"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/01902148.2020.1753266","volume":"46","author":"Kast R.E.","year":"2020","unstructured":"Kast R.E.; Dapsone as treatment adjunct in ARDS. Exp Lung Res  2020,46(5),157-161","journal-title":"Exp Lung Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"Al-Kuraishy H.M.","year":"2022","unstructured":"Al-Kuraishy H.M.; Al-Gareeb A.I.; Al-hussaniy H.A.; Al-Harcan N.A.H.; Alexiou A.; Batiha G.E.S.; Neutrophil Extracellular Traps (NETs) and COVID-19: A new frontiers for therapeutic modality. Int Immunopharmacol  2022,104,108516","journal-title":"Int Immunopharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jmv.26217","volume":"93","author":"Lucchesi A.","year":"2021","unstructured":"Lucchesi A.; Silimbani P.; Musuraca G.; Cerchione C.; Martinelli G.; Di Carlo P.; Napolitano M.; Clinical and biological data on the use of hydroxychloroquine against SARS\u2010CoV\u20102 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease. J Med Virol  2021,93(1),124-126","journal-title":"J Med Virol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1111\/jth.15021","volume":"18","author":"Macci\u00f2 A.","year":"2020","unstructured":"Macci\u00f2 A.; Madeddu C.; Caocci G.; La Nasa G.; Multifactorial pathogenesis of COVID\u201019\u2010related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders? J Thromb Haemost  2020,18(11),3106-3108","journal-title":"J Thromb Haemost"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40545-019-0185-y","volume":"12","author":"Mahmood N.","year":"2019","unstructured":"Mahmood N.; Khan M.U.; Haq I.U.L.; Jelani F.A.; Tariq A.; A case of dapsone induced methemoglobinemia. J Pharm Policy Pract  2019,12(1),22","journal-title":"J Pharm Policy Pract"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"E196","DOI":"10.1002\/ajh.25868","volume":"95","author":"Naymagon L.","year":"2020","unstructured":"Naymagon L.; Berwick S.; Kessler A.; Lancman G.; Gidwani U.; Troy K.; The emergence of methemoglobinemia amidst the COVID \u201019 pandemic. Am J Hematol  2020,95(8),E196-E197","journal-title":"Am J Hematol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10753-022-01648-7","volume":"45","author":"Al-kuraishy H.M.","year":"2022","unstructured":"Al-kuraishy H.M.; Al-Gareeb A.I.; Al-Niemi M.S.; Aljowaie R.M.; Almutairi S.M.; Alexiou A.; Batiha G.E.S.; The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in COVID-19. Inflammation  2022,45(4),1651-1667","journal-title":"Inflammation"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e20201012","DOI":"10.1084\/jem.20201012","volume":"217","author":"Radermecker C.","year":"2020","unstructured":"Radermecker C.; Detrembleur N.; Guiot J.; Cavalier E.; Henket M.; d\u2019Emal C.; Vanwinge C.; Cataldo D.; Oury C.; Delvenne P.; Marichal T.; Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med  2020,217(12),e20201012","journal-title":"J Exp Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/08923973.2019.1678635","volume":"41","author":"Rashidian A.","year":"2019","unstructured":"Rashidian A.; Rashki A.; Abdollahi A.; Haddadi N.S.; Chamanara M.; Mumtaz F.; Dehpour A.R.; Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol  2019,41(6),607-613","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e20201707","DOI":"10.1084\/jem.20201707","volume":"218","author":"Rodrigues T.S.","year":"2021","unstructured":"Rodrigues T.S.; de S\u00e1 K.S.G.; Ishimoto A.Y.; Becerra A.; Oliveira S.; Almeida L.; Gon\u00e7alves A.V.; Perucello D.B.; Andrade W.A.; Castro R.; Veras F.P.; Toller-Kawahisa J.E.; Nascimento D.C.; de Lima M.H.F.; Silva C.M.S.; Caetite D.B.; Martins R.B.; Castro I.A.; Pontelli M.C.; de Barros F.C.; do Amaral N.B.; Giannini M.C.; Bonjorno L.P.; Lopes M.I.F.; Santana R.C.; Vilar F.C.; Auxiliadora-Martins M.; Luppino-Assad R.; de Almeida S.C.L.; de Oliveira F.R.; Batah S.S.; Siyuan L.; Benatti M.N.; Cunha T.M.; Alves-Filho J.C.; Cunha F.Q.; Cunha L.D.; Frantz F.G.; Kohlsdorf T.; Fabro A.T.; Arruda E.; de Oliveira R.D.R.; Louzada-Junior P.; Zamboni D.S.; Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med  2021,218(3),e20201707","journal-title":"J Exp Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e85712","DOI":"10.1371\/journal.pone.0085712","volume":"9","author":"Schalcher T.R.","year":"2014","unstructured":"Schalcher T.R.; Borges R.S.; Coleman M.D.; Batista J\u00fanior J.; Salgado C.G.; Vieira J.L.F.; Rom\u00e3o P.R.T.; Oliveira F.R.; Monteiro M.C.; Clinical oxidative stress during leprosy multidrug therapy: Impact of dapsone oxidation. PLoS One  2014,9(1),e85712","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00280-019-04019-6","volume":"85","author":"Sheibani M.","year":"2020","unstructured":"Sheibani M.; Nezamoleslami S.; Faghir-Ghanesefat H.; Emami A.; Dehpour A.R.; Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol  2020,85(3),563-571","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2133.2005.06559.x","volume":"152","author":"Suda T.","year":"2005","unstructured":"Suda T.; Suzuki Y.; Matsui T.; Inoue T.; Niide O.; Yoshimaru T.; Suzuki H.; Ra C.; Ochiai T.; Dapsone suppresses human neutrophil superoxide production and elastase release in a calciumdependent manner. Br J Dermatol  2005,152(5),887-895","journal-title":"Br J Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"101655","DOI":"10.1016\/j.redox.2020.101655","volume":"36","author":"Violi F.","year":"2020","unstructured":"Violi F.; Oliva A.; Cangemi R.; Ceccarelli G.; Pignatelli P.; Carnevale R.; Cammisotto V.; Lichtner M.; Alessandri F.; De Angelis M.; Miele M.C.; D\u2019Ettorre G.; Ruberto F.; Venditti M.; Pugliese F.; Mastroianni C.M.; Nox2 activation in COVID-19. Redox Biol  2020,36,101655","journal-title":"Redox Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Zhu F.; Liu X.; Zhang J.; Wang B.; Xiang H.; Cheng Z.; Xiong Y.; Zhao Y.; Li Y.; Wang X.; Peng Z.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA  2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00403-013-1409-7","volume":"306","author":"Wozel G.","year":"2014","unstructured":"Wozel G.; Blasum C.; Dapsone in dermatology and beyond. Arch Dermatol Res  2014,306(2),103-124","journal-title":"Arch Dermatol Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"Zhu Y.I.","year":"2001","unstructured":"Zhu Y.I.; Stiller M.J.; Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol  2001,45(3),420-434","journal-title":"J Am Acad Dermatol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s10787-022-01078-9","volume":"30","author":"Alomair B.M.","year":"2022","unstructured":"Alomair B.M.; Al-kuraishy H.M.; Al-Buhadily A.K.; Al-Gareeb A.I.; De Waard M.; Elekhnawy E.; Batiha G.E.S.; Is sitagliptin effective for SARS-CoV-2 infection: False or true prophecy? Inflammopharmacology  2022,30(6),2411-2415","journal-title":"Inflammopharmacology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s40001-022-00818-5","volume":"27","author":"Al-kuraishy H.M.","year":"2022","unstructured":"Al-kuraishy H.M.; Al-Fakhrany O.M.; Elekhnawy E.; Al-Gareeb A.I.; Alorabi M.; De Waard M.; Albogami S.M.; Batiha G.E.S.; Traditional herbs against COVID-19: Back to old weapons to combat the new pandemic. Eur J Med Res  2022,27(1),186","journal-title":"Eur J Med Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/jcm10010050","volume":"10","author":"Scholkmann F.","year":"2020","unstructured":"Scholkmann F.; Restin T.; Ferrari M.; Quaresima V.; The role of methemoglobin and carboxyhemoglobin in COVID-19: A review. J Clin Med  2020,10(1),50","journal-title":"J Clin Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1111\/jdv.17394","volume":"35","author":"Tripathi T.","year":"2021","unstructured":"Tripathi T.; Singh A.R.; Kapoor R.; Sinha A.; Ghosh S.; Kaur K.; Pokhariya D.; Maity S.; Tapadar A.; Chandra A.; Dapsoneinduced methaemoglobinaemia in leprosy: A close mimic of \u2018happy hypoxia\u2019 in the COVID\u201019 pandemic. J Eur Acad Dermatol Venereol  2021,35(9),e568-e571","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/antibiotics10121444","volume":"10","author":"Alotaibi B.","year":"2021","unstructured":"Alotaibi B.; Negm W.A.; Elekhnawy E.; El-Masry T.A.; Elseady W.S.; Saleh A.; Alotaibi K.N.; El-Sherbeni S.A.; Antibacterial, immunomodulatory, and lung protective effects of Boswelliadalzielii Oleoresin ethanol extract in pulmonary diseases: In vitro and in vivo studies. Antibiotics  2021,10(12),1444","journal-title":"Antibiotics"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10787-022-01070-3","volume":"30","author":"Batiha G.E.S.","year":"2022","unstructured":"Batiha G.E.S.; Al-Gareeb A.I.; Elekhnawy E.; Al-kuraishy H.M.; Potential role of lipoxin in the management of COVID-19: A narrative review. Inflammopharmacology  2022,30(6),1993-2001","journal-title":"Inflammopharmacology"},{"key":"ref=49","first-page":"1","author":"Nadwa E.H.","year":"2022","unstructured":"Nadwa E.H.; Al-Kuraishy H.M.; Al-Gareeb A.I.; Elekhnawy E.; Albogami S.M.; Alorabi M.; Batiha G.E.; De Waard M.; Cholinergic dysfunction in COVID-19: Frantic search and hoping for the best. Naunyn Schmiedebergs Arch Pharmacol  2022,1-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230331121735","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215363\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230331121735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:45:56Z","timestamp":1713329156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215363\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207326666230331121735","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}